Wellington Shields & Co. LLC lowered its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 14.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 104,826 shares of the company’s stock after selling 17,250 shares during the period. Express Scripts Holding makes up 2.3% of Wellington Shields & Co. LLC’s holdings, making the stock its 5th largest position. Wellington Shields & Co. LLC’s holdings in Express Scripts Holding were worth $6,692,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Dubuque Bank & Trust Co. boosted its stake in Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares during the period. TrimTabs Asset Management LLC purchased a new stake in Express Scripts Holding during the first quarter worth about $121,000. Capital Analysts LLC boosted its stake in Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after buying an additional 100 shares during the period. IHT Wealth Management LLC boosted its stake in Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after buying an additional 145 shares during the period. Finally, FNY Partners Fund LP purchased a new stake in Express Scripts Holding during the first quarter worth about $138,000. Institutional investors own 90.20% of the company’s stock.

Express Scripts Holding Company (NASDAQ ESRX) traded up 1.00% during mid-day trading on Friday, hitting $60.90. 1,474,150 shares of the stock traded hands. The firm’s 50-day moving average price is $62.85 and its 200-day moving average price is $64.55. The firm has a market cap of $35.17 billion, a P/E ratio of 10.57 and a beta of 0.90. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. During the same quarter in the prior year, the firm posted $1.57 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. On average, equities analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/wellington-shields-co-llc-cuts-position-in-express-scripts-holding-company-esrx/1473778.html.

Several research firms recently weighed in on ESRX. UBS AG set a $71.00 target price on shares of Express Scripts Holding and gave the company a “hold” rating in a research note on Tuesday, April 25th. BidaskClub cut shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research note on Friday, August 4th. Morgan Stanley increased their target price on shares of Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a research note on Thursday. Cowen and Company reiterated an “outperform” rating and issued a $83.00 target price on shares of Express Scripts Holding in a research note on Friday, June 9th. Finally, Evercore ISI reduced their target price on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research note on Wednesday, April 26th. Four analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $71.17.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the sale, the vice president now owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.